• Brain-to-Spinal Control of Allodynia Laterality and Duration

  2026-09-24

  Huo and colleagues identify a contralateral pathway from Oprm1-expressing lateral parabrachial neurons through hypothalamic Pdyn neurons to the spinal dorsal horn that restrains the spread and persistence of mechanical allodynia in mice. The findings connect pain laterality and duration to descending circuit control, while highlighting a pathway that can be experimentally separated from tools used to manipulate glutamatergic signaling.

• CX-4945 (Silmitasertib): CK2 Inhibition & Evidence

  2026-09-23

  CX-4945, also called Silmitasertib, is an ATP-competitive CK2 inhibitor used to investigate cancer-cell signaling, apoptosis, and cell-cycle regulation. Product data report activity in cancer-cell models, while a 2026 rat stroke study provides separate evidence that CK2 inhibition can partially mitigate HFPO-DA-aggravated ischemic injury.

• HLY78: Wnt/β-Catenin Pathway Modulator Workflows

  2026-09-23

  HLY78 provides ligand-dependent control of Wnt/β-catenin signaling for zebrafish embryogenesis, hematopoietic marker studies, and mechanistic fibrosis experiments. This guide translates its Axin-LRP6 mechanism into practical workflows, controls, and troubleshooting strategies while separating validated findings from research hypotheses.

• PBK and AKT Signaling in Intrahepatic Cholangiocarcinoma

  2026-09-22

  This study integrates TCGA differential expression, WGCNA, protein-interaction analysis, and experimental validation to identify PBK as a candidate driver of intrahepatic cholangiocarcinoma progression. Its findings link PBK overexpression with aggressive cellular phenotypes and increased AKT phosphorylation, while also highlighting the need for independent clinical validation.

• CX-4945 (Silmitasertib) CK2 Research Workflows

  2026-09-22

  CX-4945 (Silmitasertib) supports mechanism-focused CK2 inhibition workflows spanning cancer signaling, apoptosis, and cell-cycle analysis. Its emerging host-pathogen application provides a practical way to test whether CK2-dependent protein stability contributes to viral replication, while matched genetic controls help distinguish target engagement from nonspecific toxicity.

• DNA Frameworks Improve Enzymatic Oligonucleotide Synthesis

  2026-09-21

  Li and colleagues developed a tetrahedral DNA nanostructure interface that organizes primers for more accessible terminal deoxynucleotidyl transferase activity. The framework improved substrate presentation, reduced deletion errors in patterned sequences, and supported a 60-nucleotide information-bearing product with a reported stepwise yield of 96.82%.

• AMG 9810: Stress-Resolved TRPV1 Assays

  2026-09-21

  AMG 9810 enables selective dissection of TRPV1-driven calcium and CGRP signaling from broader metabolic-stress adaptation. This guide translates AMPK–SQSTM1 findings into a rigorous assay strategy for sensory neuron signaling studies and pain mechanism research.

• Resazurin Cell Viability Assay Kit Workflow

  2026-09-20

  Build a sensitive, non-destructive cell viability assay around resazurin reduction, with practical guidance for screening, dose-response studies, and mechanistic oncology workflows. Learn how to pair fluorescent readouts with controls and orthogonal apoptosis measurements for more defensible results.

• S1P/S1PR3 Drives Neuronal Apoptosis After ICH

  2026-09-19

  The reference study identifies an S1P/S1PR3–TNF-α–caspase-3 axis that contributes to neuronal apoptosis after acute intracerebral hemorrhage. By combining a mouse ICH model with HT22-cell experiments and pharmacological S1PR3 inhibition, it links receptor activity to inflammatory and apoptotic signaling while positioning S1PR3 as a potential neuroprotective target.

• Ibotenic Acid: NMDA Receptor Agonist Workflows

  2026-09-18

  Build time-resolved excitotoxicity and circuit-mapping studies with Ibotenic acid, an NMDA receptor agonist that links behavioral, biochemical, immediate-early gene, and histological readouts. This workflow emphasizes formulation control, dose–time separation, and assay selection for reproducible neuroscience research and neurodegenerative disease models.

• Direct Mouse Genotyping Kit Plus for SCA3 Models

  2026-09-18

  The Direct Mouse Genotyping Kit Plus simplifies tissue-to-PCR workflows for transgene detection, knockout confirmation, and colony decisions without DNA purification. Its high-fidelity PCR master mix with dye reagents also supports clean gel-based interpretation when researchers are validating complex mouse disease models such as SCA3/MJD.

• Direct Mouse Genotyping Kit Plus for SCA3

  2026-09-17

  The Direct Mouse Genotyping Kit Plus strengthens genotype-to-phenotype workflows in SCA3 mouse research. This article connects direct PCR genotyping with the reference study’s neuroinflammation and autophagy findings while defining practical controls and limitations.

• Rifampin Workflows for Transcription Research

  2026-09-17

  Rifampin is a mechanism-defined rifamycin antibiotic for dissecting bacterial transcription, resistance, and synthetic biology circuits. This practical guide covers stock preparation, exposure design, controls, data interpretation, and troubleshooting for reproducible bench workflows.

• HotStart™ Universal 2X Green qPCR Master Mix

  2026-09-16

  A scenario-based guide to using HotStart™ Universal 2X Green qPCR Master Mix (SKU K1170) for gene expression follow-up in cell viability, proliferation, and cytotoxicity studies. It addresses assay variability, inhibitor control, melt curve analysis, data normalization, and practical vendor selection.

• MK-0812 and the Gut–Liver Axis in MASH Research

  2026-09-16

  A translational framework for using MK-0812 to test whether CCR2-dependent monocyte trafficking connects intestinal dysfunction with hepatic inflammation in MASH models.

8115 records 1/541 page Next 12345 下5页 Last page